Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1076122.RAU-AtlrRPfgEqGQ-phE_TGl0mfldirV9-CVDpveQ9av8130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1076122.RAU-AtlrRPfgEqGQ-phE_TGl0mfldirV9-CVDpveQ9av8130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1076122.RAU-AtlrRPfgEqGQ-phE_TGl0mfldirV9-CVDpveQ9av8130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1076122.RAU-AtlrRPfgEqGQ-phE_TGl0mfldirV9-CVDpveQ9av8130_provenance.
- NP1076122.RAU-AtlrRPfgEqGQ-phE_TGl0mfldirV9-CVDpveQ9av8130_assertion description "[To determine whether 1 of 2 vaccines based on dendritic cells (DCs) and poxvectors encoding CEA (carcinoembryonic antigen) and MUC1 (PANVAC) would lengthen survival in patients with resected metastases of colorectal cancer (CRC).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1076122.RAU-AtlrRPfgEqGQ-phE_TGl0mfldirV9-CVDpveQ9av8130_provenance.
- NP1076122.RAU-AtlrRPfgEqGQ-phE_TGl0mfldirV9-CVDpveQ9av8130_assertion evidence source_evidence_literature NP1076122.RAU-AtlrRPfgEqGQ-phE_TGl0mfldirV9-CVDpveQ9av8130_provenance.
- NP1076122.RAU-AtlrRPfgEqGQ-phE_TGl0mfldirV9-CVDpveQ9av8130_assertion SIO_000772 23657083 NP1076122.RAU-AtlrRPfgEqGQ-phE_TGl0mfldirV9-CVDpveQ9av8130_provenance.
- NP1076122.RAU-AtlrRPfgEqGQ-phE_TGl0mfldirV9-CVDpveQ9av8130_assertion wasDerivedFrom befree-2016 NP1076122.RAU-AtlrRPfgEqGQ-phE_TGl0mfldirV9-CVDpveQ9av8130_provenance.
- NP1076122.RAU-AtlrRPfgEqGQ-phE_TGl0mfldirV9-CVDpveQ9av8130_assertion wasGeneratedBy ECO_0000203 NP1076122.RAU-AtlrRPfgEqGQ-phE_TGl0mfldirV9-CVDpveQ9av8130_provenance.
- befree-2016 importedOn "2016-02-19" NP1076122.RAU-AtlrRPfgEqGQ-phE_TGl0mfldirV9-CVDpveQ9av8130_provenance.